[go: up one dir, main page]

CN117100459A - Valve stent and valve prosthesis - Google Patents

Valve stent and valve prosthesis Download PDF

Info

Publication number
CN117100459A
CN117100459A CN202311360161.7A CN202311360161A CN117100459A CN 117100459 A CN117100459 A CN 117100459A CN 202311360161 A CN202311360161 A CN 202311360161A CN 117100459 A CN117100459 A CN 117100459A
Authority
CN
China
Prior art keywords
stent
valve
anchor
hook
bracket
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202311360161.7A
Other languages
Chinese (zh)
Other versions
CN117100459B (en
Inventor
孙嘉康
叶升成
卢倩
张汇海
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Xinjian Technology Co ltd
Original Assignee
Beijing Xinjian Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Xinjian Technology Co ltd filed Critical Beijing Xinjian Technology Co ltd
Priority to CN202311360161.7A priority Critical patent/CN117100459B/en
Priority to CN202411010087.0A priority patent/CN118924494A/en
Publication of CN117100459A publication Critical patent/CN117100459A/en
Application granted granted Critical
Publication of CN117100459B publication Critical patent/CN117100459B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2463Implants forming part of the valve leaflets

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

本发明公开了一种瓣膜支架及瓣膜假体。所述瓣膜支架包括:外层支架,其垂向投影的外轮廓呈椭圆形或类椭圆形;内层支架,置于外层支架内并与外层支架之间保持预定间隙;内层支架用于构造出筒状流道;内层支架的顶部与外层支架的顶部可拆卸连接;锚固组件,包括多个锚固钩,多个锚固钩安装于外层支架的底部或内层支架的底部,多个锚固钩具有不同弯折角度和长度,每个锚固钩的尾端与外层支架的外轮廓面抵接。本申请的瓣膜支架,外层支架支撑部分的轮廓与原生三尖瓣瓣环形状匹配,不需要进行较大的过盈支撑尺寸即能够与原生三尖瓣瓣环具有较高的匹配度。同时采用不同弯折角度和长度的锚固钩,具有良好的锚固效果。

The invention discloses a valve stent and a valve prosthesis. The valve stent includes: an outer stent, the vertically projected outer contour of which is oval or elliptical-like; an inner stent, which is placed within the outer stent and maintains a predetermined gap with the outer stent; the inner stent is To construct a cylindrical flow channel; the top of the inner bracket and the top of the outer bracket are detachably connected; the anchor component includes a plurality of anchor hooks, and the plurality of anchor hooks are installed at the bottom of the outer bracket or the bottom of the inner bracket, The plurality of anchor hooks have different bending angles and lengths, and the tail end of each anchor hook is in contact with the outer contour surface of the outer bracket. In the valve stent of the present application, the contour of the outer stent support part matches the shape of the native tricuspid valve annulus, and can achieve a high degree of matching with the native tricuspid valve annulus without the need for a larger interference support size. At the same time, anchoring hooks with different bending angles and lengths are used to achieve good anchoring effects.

Description

瓣膜支架及瓣膜假体Valve stents and valve prostheses

技术领域Technical field

本发明涉及医疗器械领域,具体涉及瓣膜支架及瓣膜假体。The present invention relates to the field of medical devices, specifically to valve stents and valve prostheses.

背景技术Background technique

心脏由于先天性或后天性原因会发生多种瓣膜类疾病,这些瓣膜类疾病会直接或间接影响人们身心健康,当心脏瓣膜病变严重时就需要用人工瓣膜假体来置换病变的天然瓣膜。现阶段,经皮微创手术正在快速发展,这种技术可以通过导管进入身体内,释放瓣膜假体,实现治疗瓣膜疾病的效果。这种瓣膜假体目前已成为研究热点,并且具有巨大的市场潜力。The heart will suffer from various valve diseases due to congenital or acquired reasons. These valve diseases will directly or indirectly affect people's physical and mental health. When the heart valve disease is serious, artificial valve prostheses need to be used to replace the diseased natural valves. At this stage, percutaneous minimally invasive surgery is developing rapidly. This technology can enter the body through a catheter and release the valve prosthesis to achieve the effect of treating valve diseases. This kind of valve prosthesis has become a research hotspot and has huge market potential.

现阶段,经导管进入人体的瓣膜假体,为有效避免瓣周漏,会利用径向过盈来撑起病变瓣膜。但径向过盈的瓣膜假体容易干涉患者的原生组织,对患者造成伤害,导致产生左室流出道阻塞或房室传导异常等并发症。At present, valve prostheses that enter the human body through catheters use radial interference to prop up the diseased valve in order to effectively avoid paravalvular leakage. However, radial interference valve prostheses can easily interfere with the patient's native tissue and cause harm to the patient, leading to complications such as left ventricular outflow tract obstruction or abnormal atrioventricular conduction.

发明内容Contents of the invention

本发明的目的在于提供一种结构稳定、减少对患者原生组织的伤害,并能够防止瓣周漏、提升治疗效果的瓣膜支架或瓣膜假体。The purpose of the present invention is to provide a valve stent or valve prosthesis that has a stable structure, reduces damage to the patient's native tissue, prevents paravalvular leakage, and improves therapeutic effects.

为了实现以上目的,本发明的一方面,提供一种瓣膜支架,包括:In order to achieve the above objectives, one aspect of the present invention provides a valve stent, including:

外层支架,其垂向投影的外轮廓呈椭圆形或类椭圆形;The outer stent has an elliptical or elliptical-like outer contour in vertical projection;

内层支架,置于所述外层支架内并与所述外层支架之间保持预定间隙;所述内层支架用于构造出筒状流道;所述内层支架的顶部与所述外层支架的顶部可拆卸连接;The inner bracket is placed in the outer bracket and maintains a predetermined gap with the outer bracket; the inner bracket is used to construct a cylindrical flow channel; the top of the inner bracket is in contact with the outer bracket. The top of the layer bracket is removable;

锚固组件,包括多个锚固钩,多个锚固钩安装于外层支架的底部或所述内层支架的底部,所述多个锚固钩具有不同弯折角度和长度,每个锚固钩的尾端与外层支架的外轮廓面抵接。An anchor assembly includes a plurality of anchor hooks. The plurality of anchor hooks are installed at the bottom of the outer bracket or the bottom of the inner bracket. The plurality of anchor hooks have different bending angles and lengths. The tail end of each anchor hook Contact with the outer surface of the outer bracket.

在一些实施方案中,所述外层支架垂向投影的外轮廓被划分为多条曲线段,垂向投影落入同一曲线段的锚固钩的弯折角度和长度相同。In some embodiments, the vertically projected outer contour of the outer stent is divided into a plurality of curved segments, and the anchoring hooks that vertically projected into the same curved segment have the same bending angle and length.

在一些实施方案中,所述内层支架的垂向投影为圆形或圆环形;锚固组件中锚固钩的投影延伸线相交于所述圆形或圆环形的圆心并均分所述圆形或圆环形。In some embodiments, the vertical projection of the inner stent is a circle or annular shape; the projected extension line of the anchor hook in the anchor assembly intersects at the center of the circle or annular shape and evenly divides the circle. shaped or circular.

在一些实施方案中,所述内层支架的垂向投影为椭圆形或类椭圆形;所述内层支架的垂向投影与所述外层支架的垂向投影同中心且平行,即中心重合,内层支架的垂向投影轮廓与外层支架的垂向投影轮廓平行。In some embodiments, the vertical projection of the inner stent is elliptical or elliptical-like; the vertical projection of the inner stent is concentric and parallel to the vertical projection of the outer stent, that is, the centers coincide , the vertical projection profile of the inner stent is parallel to the vertical projection profile of the outer stent.

在一些实施方案中,所述外层支架包括沿瓣膜支架轴向依次布置的渐缩部、支撑部和支架部;所述渐缩部自所述支撑部的顶部向所述瓣膜支架的轴心方向渐缩收拢;所述支撑部和所述支架部的交界处为水平交界面;In some embodiments, the outer stent includes a tapered portion, a supporting portion and a stent portion arranged sequentially along the axial direction of the valve stent; the tapering portion extends from the top of the supporting portion toward the axis of the valve stent. The direction gradually shrinks; the interface between the support part and the bracket part is a horizontal interface;

所述锚固组件中锚固钩的尾端与所述水平交界面对齐。The tail end of the anchor hook in the anchor assembly is aligned with the horizontal interface.

在一些实施方案中,所述椭圆形或类椭圆形轮廓划分为第一曲线段、第二曲线段和第三曲线段;In some embodiments, the elliptical or elliptical-like profile is divided into a first curve segment, a second curve segment and a third curve segment;

所述第一曲线段包含椭圆形或类椭圆形轮廓的长轴尖端,所述外层支架中垂向投影为第一曲线段的架体被配置在隔叶区;垂向投影为第二曲线段的架体被配置在后叶区;垂向投影为第三曲线段的架体被配置在前叶区。The first curve segment includes the tip of the major axis of an elliptical or elliptical profile, and the frame body of the outer stent whose vertical projection is the first curve segment is configured in the partition area; the vertical projection is the second curve The frame body of the segment is arranged in the posterior leaf area; the frame body of the vertically projected third curve segment is arranged in the front leaf area.

在一些实施方案中,所述锚固钩的个数为6-9个,所述第一曲线段、第二曲线段和第三曲线段对应的锚固钩的个数均为2-3个。In some embodiments, the number of anchor hooks is 6-9, and the number of anchor hooks corresponding to the first curve segment, the second curve segment and the third curve segment is 2-3.

在一些实施方案中,垂向投影位于第一曲线段内的锚固钩为第一锚固钩;垂向投影位于第二曲线段内的锚固钩为第二锚固钩;垂向投影位于第三曲线段内的锚固钩为第三锚固钩;In some embodiments, the anchor hook whose vertical projection is located in the first curve segment is the first anchor hook; the anchor hook whose vertical projection is located in the second curve segment is the second anchor hook; and the vertical projection is located in the third curve segment. The anchor hook inside is the third anchor hook;

所述瓣膜支架的侧向投影高度为28-33mm;第一锚固钩的侧向投影高度为10-17mm;第二锚固钩的侧向投影高度为8-14mm;第三锚固钩的侧向投影高度为8-14mm。The lateral projection height of the valve stent is 28-33mm; the lateral projection height of the first anchor hook is 10-17mm; the lateral projection height of the second anchor hook is 8-14mm; the lateral projection height of the third anchor hook Height is 8-14mm.

在一些实施方案中,所述锚固钩包括下延部、弯折部和上延部;In some embodiments, the anchor hook includes a downward extension, a bend, and an upward extension;

第一锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为20-35°;第二锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为25-35°;第三锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为25-50°。The angle between the center line of the downward extension of the first anchor hook and the axis of the valve stent is 20-35°; the angle between the center line of the downward extension of the second anchor hook and the axis of the valve stent is 25-35°. °; The angle between the center line of the lower extension of the third anchor hook and the axis of the valve stent is 25-50°.

在一些实施例中,所述支架部包括周向阵列的多个V形结构,所述支撑部包括周向阵列的多个W形结构,所述渐缩部包括周向阵列的多个Y形结构;In some embodiments, the support portion includes a circumferential array of a plurality of V-shaped structures, the support portion includes a circumferential array of a plurality of W-shaped structures, and the tapered portion includes a circumferential array of a plurality of Y-shaped structures. structure;

V形结构、W形结构和Y形结构的数量一一对应,每个V形结构的两个顶端与其对应的W形结构的两个底端固定连接;Y形结构的两个底端与W形结构的两个顶端连接,Y形结构向所述瓣膜支架的轴心方向渐缩收拢,且在其顶端设有与所述内层支架连接的凸点。The numbers of V-shaped structures, W-shaped structures and Y-shaped structures correspond one to one. The two top ends of each V-shaped structure are fixedly connected to the two bottom ends of the corresponding W-shaped structure; the two bottom ends of the Y-shaped structure are connected to the W-shaped structure. The two top ends of the Y-shaped structure are connected, the Y-shaped structure gradually shrinks toward the axial direction of the valve stent, and a protruding point connected to the inner layer stent is provided on its top end.

在一些实施例中,V形结构的两个顶端和W形结构的两个底端一体成型。In some embodiments, the two top ends of the V-shaped structure and the two bottom ends of the W-shaped structure are integrally formed.

在一些实施例中,所述外层支架的顶端高于或等于内层支架的顶端,所述外层支架的最低端高于或等于所述内层支架的最低端。In some embodiments, the top of the outer stent is higher than or equal to the top of the inner stent, and the lowest end of the outer stent is higher than or equal to the lowest end of the inner stent.

在一些实施例中,所述外层支架的最大支撑轮廓为人体原生瓣环轮廓的1.1-1.2倍。In some embodiments, the maximum support profile of the outer stent is 1.1-1.2 times the profile of the human native valve annulus.

在一些实施例中,所述内层支架的支撑轮廓周长与所述外层支架的支撑轮廓周长之比为1 : 2 – 3 : 5。In some embodiments, the ratio of the support profile perimeter of the inner stent to the support profile perimeter of the outer stent is 1:2-3:5.

根据本发明的另一方面,还提供了一种瓣膜假体,包括如上技术方案中所述的瓣膜支架,以及缝合膜和瓣叶,所述缝合膜围设于所述外层支架和内层支架以形成密封结构;所述瓣叶固定连接于所述内层支架侧壁处的缝合膜上。According to another aspect of the present invention, a valve prosthesis is also provided, including the valve stent as described in the above technical solution, and a suture membrane and a valve leaflet. The suture membrane is surrounded by the outer stent and the inner layer. The stent is used to form a sealing structure; the leaflets are fixedly connected to the suture membrane at the side wall of the inner stent.

根据本发明的再一方面,还提供了一种将上述瓣膜支架或瓣膜假体用于制备医疗器械的用途,所述医疗器械优选为心脏瓣膜假体,更优选为三尖瓣瓣膜假体。According to another aspect of the present invention, there is also provided a use of the above-mentioned valve stent or valve prosthesis for preparing a medical device. The medical device is preferably a heart valve prosthesis, and more preferably a tricuspid valve prosthesis.

与现有技术相比,本发明所述的瓣膜假体具有以下有益效果:Compared with the prior art, the valve prosthesis of the present invention has the following beneficial effects:

1.本申请中的瓣膜支架,外层支架的支撑部分的轮廓为椭圆形或类椭圆形,与原生三尖瓣瓣环形状匹配,不需要进行较大的过盈支撑尺寸即能够与原生三尖瓣瓣环具有较高的匹配度。1. For the valve stent in this application, the outline of the support part of the outer stent is oval or elliptical, matching the shape of the native tricuspid valve annulus, and can match the shape of the native tricuspid valve annulus without requiring a large interference support size. The cusp annulus has a high degree of matching.

2.本申请中的瓣膜支架采用与三尖瓣瓣环匹配的支撑轮廓,由于放置位置具有确定形,故设置在瓣膜支架上的锚固钩根据所对应的安装位置采用了不同弯折角度和长度,以适配其安装位置处所对应原生组织的结构特点,具有更加良好的锚固效果。2. The valve stent in this application adopts a support profile that matches the tricuspid valve annulus. Since the placement position has a certain shape, the anchor hooks provided on the valve stent adopt different bending angles and lengths according to the corresponding installation positions. , to adapt to the structural characteristics of the corresponding native tissue at its installation location, and have a better anchoring effect.

3、本申请所提供的瓣环支架,相较于现有技术,其过盈比较小,但能够提供稳定地径向支撑力,并利用不同结构和位置的锚固钩进行瓣膜支架的固定,减少对原生组织的干涉,减轻对患者的伤害。3. The annulus stent provided in this application has a smaller interference ratio than the existing technology, but can provide stable radial support force, and uses anchor hooks of different structures and positions to fix the valve stent, reducing Interference with native tissue reduces harm to patients.

附图说明Description of drawings

图1为根据本申请实施例示出的一种瓣膜支架的结构示意图;Figure 1 is a schematic structural diagram of a valve stent according to an embodiment of the present application;

图2为图1所示瓣膜支架的垂向投影图;Figure 2 is a vertical projection of the valve stent shown in Figure 1;

图3为根据本申请一些实施例示出的外层支架的结构示意图;Figure 3 is a schematic structural diagram of an outer stent according to some embodiments of the present application;

图4为图3所示外层支架的垂向投影图;Figure 4 is a vertical projection of the outer bracket shown in Figure 3;

图5为根据本申请一些实施例示出的外层支架的结构示意图;Figure 5 is a schematic structural diagram of an outer stent according to some embodiments of the present application;

图6为根据本申请一些实施例示出的内层支架的结构示意图;Figure 6 is a schematic structural diagram of an inner stent according to some embodiments of the present application;

图7为根据本申请一些实施例示出的外层支架轮廓划分图;Figure 7 is an outline diagram of an outer stent according to some embodiments of the present application;

图8为根据本申请一些实施例示出的锚固组件中锚固钩的结构示意图;Figure 8 is a schematic structural diagram of an anchor hook in an anchor assembly according to some embodiments of the present application;

图9为根据本申请一些实施例示出的锚固钩的个数及位置设计思路展示图;Figure 9 is a diagram showing the number and position design ideas of anchor hooks according to some embodiments of the present application;

图10为根据本申请一些实施例示出的锚固组件安装于外层支架的结构示意图;Figure 10 is a schematic structural diagram of an anchor assembly installed on an outer bracket according to some embodiments of the present application;

图11为根据本申请一些实施例示出的瓣膜假体的正视图;Figure 11 is a front view of a valve prosthesis according to some embodiments of the present application;

图12为图11所示瓣膜假体的俯视图;Figure 12 is a top view of the valve prosthesis shown in Figure 11;

图13为根据本申请一些实施例示出的瓣膜假体的安装示意图。Figure 13 is a schematic diagram of the installation of a valve prosthesis according to some embodiments of the present application.

附图标记:Reference signs:

100-外层支架; 110-渐缩部;120-支撑部;130-支架部;140-凸点;200-内层支架;210-锚点;300-锚固组件;310-第一锚固钩;320-第二锚固钩;330-第三锚固钩;301-下延部;302-弯折部;303-上延部;400-缝合膜;500-瓣叶组件;600-三尖瓣瓣环。100-outer bracket; 110-tapering part; 120-support part; 130-bracket part; 140-bump; 200-inner bracket; 210-anchor point; 300-anchoring component; 310-first anchor hook; 320-second anchoring hook; 330-third anchoring hook; 301-lower extension; 302-bending part; 303-upper extension; 400-suture membrane; 500-valve leaflet assembly; 600-tricuspid valve annulus .

实施方式Implementation

为使本发明的上述目的、特征和优点能够更加明显易懂,下面结合附图对本发明的具体实施方式做详细的说明。在下面的描述中阐述了很多具体细节以便于充分理解本发明。但是本发明能够以很多不同于在此描述的其它方式来实施,本领域技术人员可以在不违背本发明内涵的情况下做类似改进,因此本发明不受下面公开的具体实施的限制。In order to make the above objects, features and advantages of the present invention more obvious and easy to understand, the specific embodiments of the present invention will be described in detail below with reference to the accompanying drawings. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the invention. However, the present invention can be implemented in many other ways different from those described here. Those skilled in the art can make similar improvements without departing from the connotation of the present invention. Therefore, the present invention is not limited to the specific implementation disclosed below.

应当明确,所描述的实施例仅仅是本申请一部分实施例,而不是全部的实施例。基于本申请中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本申请保护的范围。It should be clear that the described embodiments are only some of the embodiments of the present application, rather than all of the embodiments. Based on the embodiments in this application, all other embodiments obtained by those of ordinary skill in the art without making creative efforts fall within the scope of protection of this application.

在本申请实施例中使用的术语是仅仅出于描述特定实施例的目的,而非旨在限制本申请。在本申请实施例和所附权利要求书中所使用的单数形式的“一种”、“所述”和“该”也旨在包括多数形式,除非上下文清楚地表示其他含义。The terminology used in the embodiments of the present application is only for the purpose of describing specific embodiments and is not intended to limit the present application. As used in the embodiments and the appended claims, the singular forms "a," "the" and "the" are intended to include the plural forms as well, unless the context clearly dictates otherwise.

术语“底部”、“顶部”、“下部”、“内”、“外”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。The orientation or positional relationship indicated by the terms "bottom", "top", "lower", "inner", "outer", etc. are based on the orientation or positional relationship shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description. It is not intended to indicate or imply that the device or element referred to must have a specific orientation, be constructed and operate in a specific orientation, and therefore is not to be construed as a limitation of the invention.

除非另有明确的规定和限定,术语“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。Unless otherwise clearly stated and limited, the terms "connected" and "connected" should be understood in a broad sense. For example, it can be a fixed connection, a detachable connection, or an integral connection; it can be directly connected or through an intermediate connection. The medium is indirectly connected, which can be the internal connection between two components. For those of ordinary skill in the art, the specific meanings of the above terms in the present invention can be understood on a case-by-case basis.

如在本说明书中所使用的,单数形式“一”、“一个”以及“该”包括复数对象,除非内容另外明确指出外。术语“第一”、“第二”、“第三”仅用于描述目的,而不能理解为指示或暗示相对重要性。术语“或”通常是以包括“和/或”的含义而进行使用的,除非内容另外明确指出外。As used in this specification, the singular forms "a," "an," and "the" include plural referents unless the content clearly dictates otherwise. The terms "first", "second" and "third" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance. The term "or" is generally used in its sense including "and/or" unless the content clearly dictates otherwise.

如本文所用,术语“轴向”指的是支架主体的轴向,“上方”为正上方,垂向投影是指沿轴向所进行的投影,侧向投影是指沿与轴向平行方向所进行的投影。As used herein, the term "axial" refers to the axial direction of the stent body, "above" means directly above, vertical projection refers to the projection along the axial direction, and lateral projection refers to the projection along the direction parallel to the axial direction. projection.

如本文所用,术语“抵接”指的是彼此直接物理接触。As used herein, the term "butting" refers to direct physical contact with each other.

心脏生理学cardiac physiology

下面描述心脏的解剖结构以帮助理解本文公开的某些发明概念。在人类和其他脊椎动物中,心脏通常包括具有四个泵腔的肌肉器官,其中心脏的流动至少部分地由各种心脏瓣膜(即,主动脉瓣、二尖瓣、三尖瓣和肺动脉瓣)控制。瓣膜可以被配置成响应于心动周期的各个阶段(例如,舒张和收缩)期间存在的压力梯度而打开和关闭,以至少部分地控制血液到心脏的相应区域和/或血管(例如,肺血管、主动脉等)的流动。The anatomy of the heart is described below to aid in understanding certain inventive concepts disclosed herein. In humans and other vertebrates, the heart typically consists of a muscular organ with four pumping chambers, in which the flow of the heart is driven, at least in part, by various heart valves (i.e., aortic, mitral, tricuspid, and pulmonic valves) control. The valves may be configured to open and close in response to pressure gradients present during various phases of the cardiac cycle (e.g., diastole and systole) to control, at least in part, blood to corresponding regions of the heart and/or vessels (e.g., pulmonary vessels, aorta, etc.) flow.

三尖瓣是四个心脏瓣膜之一,位于右心室与右心房之间。三尖瓣确保血液从右心房流向右心室。当右心房充满血液时,三尖瓣打开,让血液进入右心室。然后右心室收缩将血液输送到肺动脉。正常情况下,心脏收缩时三尖瓣紧密关闭,使血液不会倒流到右心房。而当一些病因导致三尖关闭不全时,血液从右心室经关闭不全的三尖瓣反流入右房,即定义为三尖瓣反流 (TR)。重度TR引起或加重右心衰,导致体静脉压升高、腹腔脏器淤血,并诱发肝脾肿大、腹水、外周水肿以及胸闷乏力等临床表现,导致患者生活质量和预期寿命显著下降。The tricuspid valve is one of the four heart valves located between the right ventricle and the right atrium. The tricuspid valve ensures the flow of blood from the right atrium to the right ventricle. When the right atrium fills with blood, the tricuspid valve opens, allowing blood to enter the right ventricle. The right ventricle then contracts to deliver blood to the pulmonary artery. Normally, the tricuspid valve closes tightly when the heart contracts, preventing blood from flowing back into the right atrium. When some causes cause tricuspid regurgitation, blood flows back from the right ventricle through the incompetent tricuspid valve into the right atrium, which is defined as tricuspid regurgitation (TR). Severe TR causes or aggravates right heart failure, leads to increased systemic venous pressure, abdominal organ congestion, and induces clinical manifestations such as hepatosplenomegaly, ascites, peripheral edema, and chest tightness and fatigue, leading to a significant decrease in patients' quality of life and life expectancy.

三尖瓣环与右冠状动脉(RCA)、房室结及主动脉瓣相邻,以上结构均发挥重要的生理性作用。由于距离三尖瓣过近,因此当三尖瓣装置植入且通过过盈卡置于三尖瓣瓣环时,以上结构容易被损伤,从而给人体带来额外的安全风险,例如主动脉穿孔风险、器械与房室结接触可能诱发急性和完全性 AV 阻滞;此外,由于三尖瓣环几乎整个前环和后环都与右冠状动脉接近,因此介入瓣环成形术时右冠状动脉损伤和/或环裂的风险更高。The tricuspid annulus is adjacent to the right coronary artery (RCA), atrioventricular node, and aortic valve, and the above structures all play important physiological roles. Because it is too close to the tricuspid valve, when the tricuspid valve device is implanted and placed in the tricuspid valve annulus through an interference card, the above structures are easily damaged, thus posing additional safety risks to the human body, such as aortic perforation. Risks: Contact between the device and the atrioventricular node may induce acute and complete AV block; in addition, because almost the entire anterior and posterior annulus of the tricuspid valve annulus is close to the right coronary artery, the right coronary artery is injured during interventional annuloplasty. and/or a higher risk of ring dehiscence.

本发明公开一种瓣膜支架,其主要应用于三尖瓣介入瓣环成形术中。The invention discloses a valve stent, which is mainly used in tricuspid valve interventional annuloplasty.

本申请中的瓣膜支架包括外层支架、内层支架和锚固组件。The valve stent in this application includes an outer stent, an inner stent and an anchoring component.

外层支架outer bracket

本申请实施例中的外层支架具有压缩状态和膨胀状态。在外层支架处于膨胀状态时,外层支架垂向投影的外轮廓呈椭圆形或类椭圆形。外层支架提供最大径向支撑力的部分即为形成出椭圆形或类椭圆形垂向投影轮廓所对应的结构。The outer stent in the embodiment of the present application has a compressed state and an expanded state. When the outer stent is in an expanded state, the vertically projected outer contour of the outer stent is oval or elliptical-like. The part of the outer stent that provides the maximum radial support force is the structure corresponding to the elliptical or elliptical vertical projection profile.

在一些实施例中,外层支架为两端开口的中空网状结构,该中空网状结构具有能够被压缩和进行膨胀的特性。可参见图3或图4所示,外层支架包括沿瓣膜支架轴向依次布置的渐缩部110、支撑部120和支架部130。渐缩部110自支撑部120的顶部向瓣膜支架的轴心方向渐缩收拢;支撑部120和支架部130的交界处定义为水平交界面F。In some embodiments, the outer stent is a hollow mesh structure with openings at both ends, and the hollow mesh structure has the characteristics of being able to be compressed and expanded. As shown in FIG. 3 or FIG. 4 , the outer stent includes a tapered portion 110 , a supporting portion 120 and a stent portion 130 that are sequentially arranged along the axial direction of the valve stent. The tapered portion 110 tapers from the top of the supporting portion 120 toward the axial direction of the valve stent; the interface between the supporting portion 120 and the stent portion 130 is defined as the horizontal interface F.

本申请中,外层支架的最大径向支撑轮廓与三尖瓣原生瓣环的轮廓相同或相似,且尺寸大于或略大于原生瓣环,相对于原生瓣环形成径向过盈结构,对于采用该瓣膜支架的瓣膜假体能够与原生瓣膜位置形成良好的贴合效果。本申请中所提供的瓣膜支架需要与右冠状动脉(RCA)、房室结及主动脉瓣具有过盈配合的效果,其目的是防止瓣膜假体在安装后出现瓣周漏的情况,但为了尽可能地避免对右冠状动脉(RCA)、房室结及主动脉瓣等的影响,瓣膜支架支撑轮廓与原生瓣环轮廓的过盈比不会太大。在一些实施例中,外层支架100的最大支撑轮廓为原生瓣环轮廓的1.1-1.2倍。In this application, the maximum radial support profile of the outer stent is the same or similar to the profile of the native annulus of the tricuspid valve, and the size is larger or slightly larger than the native annulus, forming a radial interference structure relative to the native annulus. For use with The valve prosthesis of the valve stent can form a good fit with the native valve position. The valve stent provided in this application needs to have an interference fit with the right coronary artery (RCA), atrioventricular node and aortic valve. Its purpose is to prevent paravalvular leakage after the valve prosthesis is installed. However, in order to The impact on the right coronary artery (RCA), atrioventricular node and aortic valve should be avoided as much as possible, and the interference ratio between the valve stent support contour and the native valve annulus contour will not be too large. In some embodiments, the maximum support profile of the outer stent 100 is 1.1-1.2 times the native annulus profile.

在一些实施例中,支架部130包括周向阵列的多个V形结构,支撑部120包括周向阵列的多个W形结构,渐缩部110包括周向阵列的多个Y形结构。V形结构、W形结构和Y形结构的数量一一对应,每个V形结构的两个顶端与其对应的W形结构的两个底端固定连接;Y形结构的两个底端与W形结构的两个顶端连接,Y形结构向所述瓣膜支架的轴心方向渐缩收拢,且在其顶端设有与内层支架200连接的凸点。凸点用于与内层支架200的顶部连接。In some embodiments, the support portion 130 includes a circumferential array of a plurality of V-shaped structures, the support portion 120 includes a circumferential array of a plurality of W-shaped structures, and the tapered portion 110 includes a circumferential array of a plurality of Y-shaped structures. The numbers of V-shaped structures, W-shaped structures and Y-shaped structures correspond one to one. The two top ends of each V-shaped structure are fixedly connected to the two bottom ends of the corresponding W-shaped structure; the two bottom ends of the Y-shaped structure are connected to the W-shaped structure. The two top ends of the Y-shaped structure are connected, and the Y-shaped structure gradually shrinks toward the axial direction of the valve stent, and is provided with a bump connected to the inner stent 200 at its top end. The bumps are used to connect with the top of the inner bracket 200 .

在一些实施例中,V形结构的两个顶端和W形结构的两个底端一体成型。支撑部120和支架部130一体成型,可使外层支架具有较为稳固的径向支撑力。In some embodiments, the two top ends of the V-shaped structure and the two bottom ends of the W-shaped structure are integrally formed. The support part 120 and the bracket part 130 are integrally formed, so that the outer bracket has a relatively stable radial support force.

在一些实施例中,外层支架的架体还可采用网格单元构成的网状结构,例如,网格单元呈菱形。需要说明的是,本申请对于外层支架的结构不做具体限定,凡是能够提供径向支撑且能够压缩和膨胀的网格结构均落入本申请的保护范围。In some embodiments, the frame body of the outer stent may also adopt a network structure composed of grid units. For example, the grid units are in a diamond shape. It should be noted that this application does not specifically limit the structure of the outer stent. Any grid structure that can provide radial support and can be compressed and expanded falls within the protection scope of this application.

在一些实施例中,外层支架上设置有针刺,针刺的一端连接于外层支架外表面,另一端倾斜朝向外层支架的外侧。外层支架上的针刺,在瓣膜支架被输送至预定位置后能够刺入原生组织内,使瓣膜支架能够更加牢固地被固定在原生瓣环处。In some embodiments, the outer stent is provided with needles, one end of the needles is connected to the outer surface of the outer stent, and the other end is inclined toward the outside of the outer stent. The needles on the outer stent can penetrate into the native tissue after the valve stent is delivered to the predetermined position, so that the valve stent can be more firmly fixed at the native valve annulus.

形成所述外层支架的材料可以选用镍钛诺、钛合金、钴铬合金、MP35n、316不锈钢、L605、Phynox/Elgiloy(钴-铬-镍合金)、铂铬等金属,或本领域技术人员已知的其它生物相容性金属。The material forming the outer stent can be made of nitinol, titanium alloy, cobalt-chromium alloy, MP35n, 316 stainless steel, L605, Phynox/Elgiloy (cobalt-chromium-nickel alloy), platinum-chromium and other metals, or those skilled in the art Other known biocompatible metals.

可选地,外层支架还可以由可弹性或可塑性变形的材料制成,如球囊可扩张的,或者可以是响应温度变化以在收缩的递送状态和扩张的展开状态之间转变的形状记忆合金。Optionally, the outer stent may also be made from an elastically or plastically deformable material, such as a balloon-expandable, or may be shape memory that responds to temperature changes to transition between a contracted delivery state and an expanded deployed state. alloy.

在一些实施例中,外层支架还可采用镍钛合金管材切割制造,管材外径为4-50mm,根据使用者三尖瓣的实际原生瓣环尺寸选取定型后的轮廓尺寸。In some embodiments, the outer stent can also be cut and manufactured from nickel-titanium alloy tubing with an outer diameter of 4-50 mm, and the contour size after shaping is selected according to the actual native annulus size of the user's tricuspid valve.

内层支架inner stent

内层支架为两端开口的筒形结构。该筒形结构具有能够被压缩和进行膨胀的特性。内层支架的垂向投影为圆形或圆环形;或者内层支架的垂向投影为椭圆形或类椭圆形。The inner bracket is a cylindrical structure with openings at both ends. The cylindrical structure has the characteristics of being able to be compressed and expanded. The vertical projection of the inner stent is circular or annular; or the vertical projection of the inner stent is elliptical or elliptical-like.

在一些实施例中,所述内层支架为圆筒形或近似圆筒形,也或者为两端为喇叭口结构的筒形结构,参见图6,亦或者为一端为直筒形,一端为喇叭口形的筒形结构。In some embodiments, the inner support is cylindrical or nearly cylindrical, or has a cylindrical structure with bell mouth structures at both ends, see Figure 6 , or has a straight cylindrical shape at one end and a horn at the other end. Mouth-shaped cylindrical structure.

在一些实施例中,所述内层支架垂向投影的外轮廓为椭圆形或类椭圆形,其采用椭圆形或类椭圆形结构时,可采用与外层支架轮廓相同且平行的布局结构。In some embodiments, the vertically projected outer contour of the inner stent is elliptical or elliptical-like. When it adopts an elliptical or elliptical-like structure, the same and parallel layout structure as the outline of the outer stent can be used.

在一些实施例中,所述内层支架的主体部分上设有多处镂空,可以为圆形、网格形、菱形或其他图案。In some embodiments, the main body part of the inner stent is provided with multiple hollows, which may be circular, grid-shaped, diamond-shaped or other patterns.

形成内层支架的材料可以选用如镍钛诺、钛合金、钴铬合金、MP35n、316不锈钢、L605、Phynox/Elgiloy(钴-铬-镍合金)、铂铬等金属,或是本领域技术人员已知的其它生物相容性金属。The material forming the inner stent can be selected from metals such as Nitinol, titanium alloy, cobalt-chromium alloy, MP35n, 316 stainless steel, L605, Phynox/Elgiloy (cobalt-chromium-nickel alloy), platinum-chromium, or those skilled in the art. Other known biocompatible metals.

可选地,内层支架还可以由可弹性或可塑性变形的材料制成,如球囊可扩张的,或者可以是响应温度变化以在收缩的递送状态和扩张的展开状态之间转变的形状记忆合金。Alternatively, the inner stent may also be made from an elastically or plastically deformable material, such as a balloon-expandable, or may be shape memory that responds to temperature changes to transition between a contracted delivery state and an expanded, deployed state. alloy.

在一些实施例中,内层支架采用镍钛合金管材切割制造,管材外径为4-50mm,根据使用者三尖瓣的实际原生瓣环尺寸选取定型后的轮廓尺寸。In some embodiments, the inner stent is cut and manufactured from nickel-titanium alloy tubing with an outer diameter of 4-50 mm, and the shaped contour size is selected according to the actual native annulus size of the user's tricuspid valve.

锚固组件Anchor components

锚固组件包括多个锚固钩,多个锚固钩安装于外层支架的底部或内层支架的底部。可参考图1和图6,以多个锚固钩安装于内层支架底部为例进行说明。多个锚固钩具有不同弯折角度和长度,每个锚固钩的尾端与外层支架的外轮廓面抵接。The anchoring component includes a plurality of anchor hooks, and the plurality of anchor hooks are installed at the bottom of the outer bracket or the bottom of the inner bracket. Referring to Figures 1 and 6, multiple anchor hooks are installed at the bottom of the inner bracket as an example for explanation. The plurality of anchor hooks have different bending angles and lengths, and the tail end of each anchor hook is in contact with the outer contour surface of the outer bracket.

在外层支架包括渐缩部110、支撑部120和支架部130的实施例中,锚固组件中锚固钩的尾端与支撑部120和支架部130的水平交界面F对齐。支撑部120和支架部130在交界处交叉连接,交叉连接处具有交叉点,交叉点连接形成所述水平交界面F。交叉点相较于支撑部120和支架部130的其他部位,具有较优的硬度和刚度,每个锚固钩的端部被设置在交叉点附近,在锚固钩钩住原生组织后锚固钩的端部与交叉点形成对原生组织的夹持,硬度与刚度较好的交叉点与锚固钩的端部形成的夹持力会较大且持久性好。In the embodiment in which the outer bracket includes the tapered part 110 , the support part 120 and the bracket part 130 , the tail end of the anchor hook in the anchor assembly is aligned with the horizontal interface F of the support part 120 and the bracket part 130 . The support part 120 and the bracket part 130 are cross-connected at the intersection, and the cross-connection has an intersection, and the intersection points are connected to form the horizontal interface F. The intersection point has better hardness and rigidity than other parts of the support part 120 and the bracket part 130. The end of each anchor hook is set near the intersection point. After the anchor hook hooks the native tissue, the end of the anchor hook The intersection point and the intersection point form a clamping of the native tissue. The clamping force formed by the intersection point with good hardness and stiffness and the end of the anchor hook will be larger and more durable.

将锚固组件设置在内层支架上,在一种优选地方案中,每个锚固钩与内层支架一体成型,该设置可以减少瓣膜支架的缝制工序,增强与内层支架的连接强度,减少瓣膜支架出现脱钩的风险。The anchoring component is arranged on the inner stent. In a preferred solution, each anchor hook is integrally formed with the inner stent. This arrangement can reduce the sewing process of the valve stent, enhance the connection strength with the inner stent, and reduce Risk of valve stent decoupling.

三尖瓣由瓣叶、瓣环、腱索、乳头肌四个部分组成。瓣叶通常根据所处位置命名为前叶、后叶和隔叶。前叶、后叶和隔叶通过称为腱索的细而结实的绳索附着在心室的乳头肌上,乳头肌的作用是为三尖瓣瓣叶提供腱索支撑。The tricuspid valve is composed of four parts: leaflets, annulus, chordae tendineae, and papillary muscles. The valve leaflets are usually named anterior leaflet, posterior leaflet and septal leaflet according to their location. The anterior, posterior, and septal leaflets are attached to the papillary muscles of the ventricles by thin, strong cords called chordae tendineae, which provide chordal support for the tricuspid valve leaflets.

多个锚固钩的设置规则为:膨胀状态下,外层支架垂向投影的外轮廓被划分为多条曲线段,垂向投影落入同一曲线段的锚固钩的弯折角度和长度相同。The setting rules for multiple anchor hooks are: in the expanded state, the vertically projected outer contour of the outer stent is divided into multiple curve segments, and the anchor hooks whose vertical projections fall into the same curve segment have the same bending angle and length.

在一种实施例中,将椭圆形或类椭圆形轮廓划分为第一曲线段C1、第二曲线段C2和第三曲线段C3,参见图7。第一曲线段C1包含椭圆形或类椭圆形轮廓的长轴尖端,外层支架中垂向投影为第一曲线段C1的架体被配置为与隔叶区对应;垂向投影为第二曲线段C2的架体被配置为与后叶区对应;垂向投影为第三曲线段C3的架体被配置为与前叶区对应。In one embodiment, the elliptical or elliptical-shaped outline is divided into a first curve segment C1, a second curve segment C2, and a third curve segment C3, see FIG. 7 . The first curve segment C1 includes the tip of the major axis of an elliptical or quasi-elliptical profile. The vertical projection of the outer stent as the first curve segment C1 is configured to correspond to the septal leaf area; the vertical projection is the second curve. The frame of segment C2 is configured to correspond to the posterior leaf area; the frame of vertically projected third curve segment C3 is configured to correspond to the front leaf area.

在本申请中,垂向投影位于第一曲线段C1内的锚固钩为第一锚固钩310;垂向投影位于第二曲线段C2内的锚固钩为第二锚固钩320;垂向投影位于第三曲线段C3内的锚固钩为第三锚固钩330。In this application, the anchor hook vertically projected in the first curve segment C1 is the first anchor hook 310; the anchor hook vertically projected in the second curve segment C2 is the second anchor hook 320; the vertical projection located in the second curve segment C2 is the second anchor hook 320. The anchor hook in the three-curve section C3 is the third anchor hook 330 .

在一些实施例中,锚固钩的个数为6-9个,第一锚固钩310、第二锚固钩320和第三锚固钩330的设置个数均为2-3个。In some embodiments, the number of anchor hooks is 6-9, and the number of the first anchor hooks 310 , the second anchor hooks 320 and the third anchor hooks 330 is each 2-3.

在一种实施例中,第一锚固钩310的个数为3个,第二锚固钩320的个数为3个,第三锚固钩330的个数为2个。In one embodiment, the number of first anchor hooks 310 is three, the number of second anchor hooks 320 is three, and the number of third anchor hooks 330 is two.

在一些可能的实施例中,外层支架的侧向投影高度为28-33mm。第一锚固钩310(隔叶区)的侧向投影高度为8-14mm;第二锚固钩320(后叶区)的侧向投影高度为8-14mm;第三锚固钩330(前叶区)的侧向投影高度为10-17mm。In some possible embodiments, the lateral projected height of the outer stent is 28-33 mm. The lateral projection height of the first anchor hook 310 (septal leaf area) is 8-14mm; the lateral projection height of the second anchor hook 320 (posterior leaf area) is 8-14mm; the third anchor hook 330 (anterior leaf area) The lateral projection height is 10-17mm.

在一些实施例中,锚固钩包括下延部301、弯折部302和上延部303,参见图8。第一锚固钩310的下延部301的中心线与瓣膜支架轴心的角度a为25-50°;第二锚固钩320的下延部301的中心线与所述瓣膜支架轴心的角度β为25-35°;第三锚固钩330的下延部301的中心线与瓣膜支架轴心的角度γ为20-35°。In some embodiments, the anchor hook includes a lower extension portion 301, a bent portion 302, and an upper extension portion 303, see Figure 8 . The angle a between the center line of the downward extension 301 of the first anchor hook 310 and the axis of the valve stent is 25-50°; the angle β between the center line of the downward extension 301 of the second anchor hook 320 and the axis of the valve stent is is 25-35°; the angle γ between the center line of the downward extension 301 of the third anchor hook 330 and the axis of the valve stent is 20-35°.

在一些实施例中,多个锚固钩的个数及位置设计思路为:以内瓣架的垂向投影为一个圆形为例进行说明。对圆形进行圆周均分,在锚固钩个数为8的实施例中,角度为45度,参见图9,每个锚固钩的投影延伸线之间的夹角为45度。使3个第一锚固钩310位于第一曲线段C1所对应的结构上,用于钩住隔叶。3个第二锚固钩320位于第二曲线段C2所对应的结构上,用于钩住后叶。2个第三锚固钩330位于第三曲线段C3所对应的结构上,用于钩住前叶,以增加与原生瓣叶和腱索的固定。第三锚固钩330和第一锚固钩310之间不设锚固钩,以防止锚固钩钩到心室壁。In some embodiments, the design idea for the number and position of multiple anchor hooks is as follows: taking the vertical projection of the inner valve frame as a circle as an example for illustration. Divide the circle evenly. In an embodiment where the number of anchor hooks is 8, the angle is 45 degrees. See Figure 9. The angle between the projected extension lines of each anchor hook is 45 degrees. The three first anchor hooks 310 are located on the structure corresponding to the first curve segment C1 for hooking the partition leaves. The three second anchor hooks 320 are located on the structure corresponding to the second curve segment C2 and are used to hook the rear leaf. The two third anchoring hooks 330 are located on the structure corresponding to the third curve segment C3 and are used to hook the anterior leaflet to increase the fixation with the native valve leaflet and chordae tendineae. There is no anchor hook between the third anchor hook 330 and the first anchor hook 310 to prevent the anchor hook from hooking onto the ventricular wall.

第一锚固钩310、第二锚固钩320和第三锚固钩330的顶端与外层支架上的水平交界面F齐平,第一锚固钩310的最低底端低于第二锚固钩320和第三锚固钩330的最低底端。图8示出了三种锚固钩的结构对比图,由图可知,相较于第一锚固钩310和第二锚固钩320,第三锚固钩330的纵向距离要长,因为原生前叶较长,这样的设计能钩更好地钩住前叶。The top ends of the first anchor hook 310, the second anchor hook 320 and the third anchor hook 330 are flush with the horizontal interface F on the outer support, and the lowest bottom end of the first anchor hook 310 is lower than the second anchor hook 320 and the third anchor hook 320. The lowest bottom end of the three anchor hooks 330. Figure 8 shows a structural comparison diagram of three anchor hooks. It can be seen from the figure that compared with the first anchor hook 310 and the second anchor hook 320, the longitudinal distance of the third anchor hook 330 is longer because the native anterior leaflet is longer. , this design can hook the front leaf better.

三尖瓣环 (TA) 正常情况下是一个不对称的马鞍形椭圆体,具有 2 个不同的部分:一个较大的 C 形部分对应于右心房和右心室的游离壁;和一个较短的、相对直的部分,对应于隔叶和室间隔。本申请中采用不同长度的锚固钩,能够更好地适配所要锚固的原生部位,由于提高了适配度,因此本申请中的锚固组件能够使瓣膜支架实现牢固的锚定。The tricuspid annulus (TA) is normally an asymmetric saddle-shaped ellipsoid with 2 distinct segments: a larger C-shaped segment corresponding to the free walls of the right atrium and right ventricle; and a shorter , the relatively straight part, corresponding to the septal leaves and interventricular septum. The anchoring hooks of different lengths used in this application can better adapt to the native part to be anchored. Due to the improved adaptability, the anchoring assembly in this application can achieve firm anchoring of the valve stent.

在一些实施例中,锚固组件固定在外层支架上,可参照图10。锚固组件固定在外层支架上时,多个锚固钩的个数及位置设计与上述在内层支架上固定锚固组件的设计思路一致,此处不再赘述。In some embodiments, the anchoring component is fixed on the outer bracket, as shown in FIG. 10 . When the anchoring component is fixed on the outer bracket, the number and position design of the multiple anchor hooks are consistent with the above-mentioned design idea of fixing the anchoring component on the inner bracket, and will not be described again here.

锚固组件连接在外层支架上,有利于减少由于锚固钩受到原生瓣叶带动而影响内层支架的变形,且每个锚固钩的角度调整更加灵活。The anchoring component is connected to the outer stent, which is beneficial to reducing the deformation of the inner stent due to the anchor hook being driven by the native leaflets, and the angle adjustment of each anchor hook is more flexible.

内层支架和外层支架的连接Connection of inner and outer brackets

内层支架为两端开口的筒形结构,筒形结构的顶端设有用于与外层支架点连接的锚点。在一些实施方式中,可参加图6,锚点210为中间开孔的环状结构。The inner bracket is a cylindrical structure with openings at both ends, and the top of the cylindrical structure is provided with an anchor point for connecting with the outer bracket. In some embodiments, as shown in FIG. 6 , the anchor point 210 is a ring-shaped structure with a hole in the middle.

在一些实施方式中,外层支架的凸点为中间开孔的环状结构,可参见图3和图5,凸点140位于外层支架的顶端。In some embodiments, the bumps of the outer stent are annular structures with holes in the middle. See Figures 3 and 5 . The bumps 140 are located at the top of the outer stent.

外层支架套设于内层支架外侧,内层支架上的凸点与外层支架上的锚点的连接方式包括焊接、铆接、压接、缝合连接中的一种或多种组合。The outer stent is sleeved on the outside of the inner stent, and the connection method between the protruding points on the inner stent and the anchor points on the outer stent includes one or more combinations of welding, riveting, crimping, and suture connection.

在一种实施例中,层支架和外层支架还可通过柔性绑扎带(例如金属或非金属线材)绑扎相连。In one embodiment, the layer bracket and the outer layer bracket can also be tied and connected through flexible binding tapes (such as metal or non-metallic wires).

内层支架的支撑轮廓周长不小于外层支架支撑轮廓周长的二分之一。The support profile perimeter of the inner stent is not less than one-half of the support profile perimeter of the outer stent.

在一些实施例中,锚固钩弯折朝向外层支架外表面的表面上设置有针刺,针刺朝向外层支架。In some embodiments, acupuncture is provided on the surface of the anchoring hook that is bent toward the outer surface of the outer stent, and the needle punctures are directed toward the outer stent.

在一些实施例中,内层支架的支撑轮廓周长与外层支架支撑轮廓周长之比为1 :2 – 3 : 5,例如可以1 : 2 – 4 : 5或3 : 5 – 4 : 5。In some embodiments, the ratio of the support profile perimeter of the inner stent to the support profile perimeter of the outer stent is 1:2-3:5, for example, it can be 1:2-4:5 or 3:5-4:5.

在一些实施例中,外层支架的最低端应高于或等于内层支架的最低端,原因为:和原生瓣环接触的为外层支架,外层支架的底端过高会干扰瓣膜支架的释放效果,在内层支架连接锚固组件的实施例中,锚固钩需要由内层支架的底端延伸至外层支架之外,故外层支架最低端应不低于内层支架的最低端。In some embodiments, the lowest end of the outer stent should be higher than or equal to the lowest end of the inner stent. The reason is that the outer stent is in contact with the native valve annulus. If the bottom end of the outer stent is too high, it will interfere with the valve stent. In the embodiment where the inner bracket is connected to the anchor component, the anchor hook needs to extend from the bottom end of the inner bracket to the outside of the outer bracket, so the lowest end of the outer bracket should not be lower than the lowest end of the inner bracket. .

针刺和显影点Needling and developing points

在一些实施例中,锚固钩的表面和与外层支架的连接部位还设有覆膜层,覆膜层可通过覆膜、编织布缝合等形式设置。In some embodiments, the surface of the anchor hook and the connection part with the outer stent are also provided with a coating layer, and the coating layer can be provided in the form of coating, woven fabric stitching, etc.

可选地,所述覆膜层的材料可选PET、PTFE、ePTFE、PU等生物相容性好且容易内皮化的材料、或生物组织材料如猪心包、牛心包。Optionally, the material of the coating layer can be materials with good biocompatibility and easy endothelialization such as PET, PTFE, ePTFE, PU, or biological tissue materials such as porcine pericardium and bovine pericardium.

在一些实施例中,所述外层支架上设置有针刺,可参见图5或图9,所述针刺用于钉扎固定,可更加稳定地固定瓣膜支架或支架制备得到的假体。In some embodiments, the outer stent is provided with acupuncture, as shown in Figure 5 or Figure 9. The acupuncture is used for pinning and fixing, and can more stably fix the valve stent or the prosthesis prepared by the stent.

在一些实施例中,所述针刺的一端连接于外层支架外表面,另一端倾斜朝向瓣膜支架的外侧。In some embodiments, one end of the needle is connected to the outer surface of the outer stent, and the other end is inclined toward the outside of the valve stent.

在一些实施例中,所述锚固钩上设置有显影点。In some embodiments, the anchor hook is provided with a development point.

瓣膜假体valve prosthesis

本发明的另一方面,提供一种瓣膜假体,包括瓣膜支架、缝合膜以及瓣叶,所述缝合膜围设于所述瓣膜支架形成密封结构。Another aspect of the present invention provides a valve prosthesis, which includes a valve stent, a suture membrane, and a valve leaflet. The suture membrane surrounds the valve stent to form a sealing structure.

在一些实施例中,所述缝合膜的材料可选PET(聚对苯二甲酸乙二醇酯)、PTFE(聚四氟乙烯)、ePTFE(膨体聚四氟乙烯)、PU(聚酰胺)等生物相容性好且容易内皮化的材料、或生物组织材料如猪心包、牛心包。In some embodiments, the material of the suture membrane can be PET (polyethylene terephthalate), PTFE (polytetrafluoroethylene), ePTFE (expanded polytetrafluoroethylene), PU (polyamide) Materials with good biocompatibility and easy endothelialization, or biological tissue materials such as porcine pericardium and bovine pericardium.

在满足能阻挡流经瓣膜假体的血液从外层支架侧壁流出功能的条件下,所述缝合膜可以是由PET、PTFE、ePTFE、PU等纱线制成的网格缝隙密集的网格形状。Under the condition that it can block the flow of blood flowing through the valve prosthesis from the side wall of the outer stent, the suture membrane can be a mesh with dense mesh gaps made of yarns such as PET, PTFE, ePTFE, PU, etc. shape.

可选地,所述缝合膜可以与外层支架外侧壁或内侧壁连接,例如通过非金属线材绑扎相连。Optionally, the suture membrane can be connected to the lateral wall or medial wall of the outer stent, for example, through non-metallic wire binding.

在一些实施例中,所述瓣叶固定连接于包裹在内层支架侧壁处的缝合膜。In some embodiments, the leaflets are fixedly connected to a suture membrane wrapped around the side wall of the inner stent.

可选地,所述瓣叶缝合于包裹在内层支架侧壁处的缝合膜上。Optionally, the leaflets are sutured to a suture membrane wrapped around the side wall of the inner stent.

瓣膜假体包括两片人工瓣叶或三片人工瓣叶,瓣叶的一端与内层支架侧壁处的缝合膜稳定连接,瓣叶的另一端为自由端。在工作状态下,由人工瓣叶替代原生瓣叶实现开启和关闭血液通道的功能。The valve prosthesis includes two artificial valve leaflets or three artificial valve leaflets. One end of the valve leaflets is stably connected to the suture membrane on the side wall of the inner stent, and the other end of the valve leaflets is the free end. In working condition, the artificial valve leaflets replace the native valve leaflets to realize the function of opening and closing the blood channel.

瓣叶组件的制作材料包括生物组织材料或合成材料,例如,生物组织材料可以为牛心包、羊心包、猪心包或马心包组织中的任意一种,合成材料可以为聚氨酯、聚四氟乙烯或有机硅聚酯等材料。The leaflet assembly is made of materials including biological tissue materials or synthetic materials. For example, the biological tissue material can be any one of bovine pericardium, sheep pericardium, porcine pericardium or horse pericardium tissue, and the synthetic material can be polyurethane, polytetrafluoroethylene or Materials such as silicone polyester.

所述瓣膜假体具有压缩状态和膨胀状态两种形态,本发明中如无特殊强调,均为膨胀状态下的特征描述。The valve prosthesis has two forms: a compressed state and an expanded state. Unless otherwise emphasized in the present invention, the characteristics are described in the expanded state.

用途use

本发明提供前述瓣膜支架或前述瓣膜假体用于制备医疗器械的用途。The present invention provides the use of the aforementioned valve stent or the aforementioned valve prosthesis for preparing medical devices.

在一些实施例中,所述医疗器械为心脏瓣膜假体。In some embodiments, the medical device is a heart valve prosthesis.

在一些实施例中,所述医疗器械为三尖瓣瓣膜假体。In some embodiments, the medical device is a tricuspid valve prosthesis.

实施例1Example 1

本实施例提供一种瓣膜支架,其包括外层支架100、内层支架200和锚固组件300。如图1-3所示,内层支架200置于外层支架100内并与外层支架100之间保持预定间隙;内层支架200用于构造出筒状流道;内层支架200的顶部与外层支架100的顶部连接。锚固组件300包括多个锚固钩。多个锚固钩安装于内层支架200的底部,各锚固钩具有不同弯折角度和长度,每个锚固钩的尾端与外层支架100的外轮廓面抵接。This embodiment provides a valve stent, which includes an outer stent 100 , an inner stent 200 and an anchoring component 300 . As shown in Figure 1-3, the inner bracket 200 is placed inside the outer bracket 100 and maintains a predetermined gap with the outer bracket 100; the inner bracket 200 is used to construct a cylindrical flow channel; the top of the inner bracket 200 Connected to the top of the outer bracket 100 . Anchor assembly 300 includes a plurality of anchor hooks. A plurality of anchor hooks are installed at the bottom of the inner bracket 200 . Each anchor hook has a different bending angle and length. The tail end of each anchor hook is in contact with the outer contour surface of the outer bracket 100 .

外层支架100包括沿瓣膜支架轴向依次布置的渐缩部110、支撑部120和支架部130。渐缩部110自支撑部120的顶部向瓣膜支架的轴心方向渐缩收拢。支撑部120和支架部130在水平交界面F处交接。渐缩部110包括周向阵列的多个Y形结构,支撑部120包括周向阵列的多个W形结构,支架部130包括周向阵列的多个V形结构, V形结构、W形结构和Y形结构的数量一一对应,每个V形结构的两个顶端与其对应的W形结构的两个底端一体成型;Y形结构的两个底端与W形结构的两个顶端连接,Y形结构向瓣膜支架的轴心方向渐缩收拢,且在其顶端设有与内层支架200连接的凸点。凸点用于与内层支架200的顶部连接。The outer stent 100 includes a tapered portion 110, a supporting portion 120 and a stent portion 130 that are sequentially arranged along the axial direction of the valve stent. The tapered portion 110 is tapered from the top of the supporting portion 120 toward the axial direction of the valve stent. The support part 120 and the bracket part 130 meet at the horizontal interface F. The tapered portion 110 includes a plurality of Y-shaped structures in a circumferential array, the supporting portion 120 includes a plurality of W-shaped structures in a circumferential array, and the bracket portion 130 includes a plurality of V-shaped structures in a circumferential array. The V-shaped structure and the W-shaped structure Corresponding to the number of Y-shaped structures, the two top ends of each V-shaped structure are integrally formed with the two bottom ends of the corresponding W-shaped structure; the two bottom ends of the Y-shaped structure are connected to the two top ends of the W-shaped structure , the Y-shaped structure gradually shrinks toward the axial direction of the valve stent, and is provided with a convex point connected to the inner stent 200 at its top. The bumps are used to connect with the top of the inner bracket 200 .

内层支架200为两端开口的筒形结构,如图6所示,两端为喇叭口结构。内层支架200垂向投影的外轮廓为圆形。内层支架200的主体部分上设有多处镂空,可以为圆形、网格形、菱形或其他图案。The inner bracket 200 has a cylindrical structure with openings at both ends, as shown in FIG. 6 , and has a bell-shaped structure at both ends. The vertically projected outer contour of the inner bracket 200 is circular. The main body of the inner bracket 200 is provided with multiple hollows, which may be circular, grid-shaped, diamond-shaped or other patterns.

可以理解地,外层支架100和内层支架200的距离可以通过内层支架200的直径进行调节,内层支架200的直径越小,则外层支架100与内层支架200之间的距离越大。It can be understood that the distance between the outer stent 100 and the inner stent 200 can be adjusted by the diameter of the inner stent 200 . The smaller the diameter of the inner stent 200 , the smaller the distance between the outer stent 100 and the inner stent 200 . big.

由于瓣膜支架或制成的假体在瓣环处的放置位置、内层支架200与外层支架100的形状、两者的连接关系不同对瓣膜支架的性能影响较大,因此本发明对内层支架200和外层支架100的距离和结构设置的选择也较为重要,在本发明的实施方案中内层支架200的支撑轮廓周长不小于外层支架100支撑轮廓周长的二分之一。在一些实施例中,内层支架200的支撑轮廓周长与外层支架100支撑轮廓周长之比为1 : 2 – 3 : 5,例如可以1 : 2 – 4 :5或3 : 5 – 4 : 5。外层支架100和内层支架200之间的距离过小会使得瓣膜支架的径向支撑不稳,植入后原生瓣环挤压内层支架200,影响瓣叶的正常工作。Since the placement position of the valve stent or the manufactured prosthesis at the valve annulus, the shapes of the inner stent 200 and the outer stent 100, and the connection relationship between the two have a greater impact on the performance of the valve stent, the present invention has a greater impact on the inner stent 200 and outer stent 100. The selection of the distance and structural settings between the stent 200 and the outer stent 100 is also important. In the embodiment of the present invention, the support profile perimeter of the inner stent 200 is not less than half of the support profile perimeter of the outer stent 100 . In some embodiments, the ratio of the support profile perimeter of the inner stent 200 to the support profile perimeter of the outer stent 100 is 1:2-3:5, for example, it can be 1:2-4:5 or 3:5-4:5. . If the distance between the outer stent 100 and the inner stent 200 is too small, the radial support of the valve stent will be unstable, and the native valve annulus will squeeze the inner stent 200 after implantation, affecting the normal operation of the valve leaflets.

内层支架200和外层支架100的成型方式包括但不限于激光切割、剪切和线切割。相对于单层瓣膜支架,该双层支架具有较好的稳定性,外层支架100受到心脏跳动挤压时,内层支架200避免受到影响,保持瓣叶的正常开合功能,实现更好的治疗效果。The forming methods of the inner bracket 200 and the outer bracket 100 include but are not limited to laser cutting, shearing and wire cutting. Compared with the single-layer valve stent, the double-layer stent has better stability. When the outer stent 100 is squeezed by the beating of the heart, the inner stent 200 is prevented from being affected, maintaining the normal opening and closing functions of the valve leaflets, and achieving better results. treatment effect.

锚固组件300中的多个锚固钩安装于内层支架200的底部,每个锚固钩与内层支架200一体成型。参见图7,外层支架100垂向投影的外轮廓被划分为第一曲线段C1、第二曲线段C2和第三曲线段C3。垂向投影位于第一曲线段C1内的锚固钩为第一锚固钩310;垂向投影位于第二曲线段C2内的锚固钩为第二锚固钩320;垂向投影位于第二曲线段C2内的锚固钩为第三锚固钩330。第一锚固钩310被配置在原生前叶与后叶中间的位置,并用于与原生瓣叶和腱索钩连。第二锚固钩320被配置在原生后叶与隔叶中间的位置,并用于与后叶钩连;第三锚固钩330用于配置在原生组织的前叶与隔叶中间对应的位置,并用于与前叶钩连。A plurality of anchor hooks in the anchor assembly 300 are installed at the bottom of the inner bracket 200 , and each anchor hook is integrally formed with the inner bracket 200 . Referring to FIG. 7 , the vertically projected outer contour of the outer stent 100 is divided into a first curve segment C1 , a second curve segment C2 and a third curve segment C3 . The anchor hook vertically projected within the first curve segment C1 is the first anchor hook 310; the anchor hook vertically projected within the second curve segment C2 is the second anchor hook 320; the vertical projection located within the second curve segment C2 The anchor hook is the third anchor hook 330 . The first anchoring hook 310 is disposed in the middle of the native anterior leaflet and the posterior leaflet, and is used to hook with the native valve leaflet and chordae tendineae. The second anchoring hook 320 is disposed at a position between the native posterior leaflet and the septal leaflet, and is used to hook the posterior leaflet; the third anchoring hook 330 is used to be disposed at a corresponding position between the anterior leaflet and the septal leaflet of the native tissue, and is used to Hooked with the front leaf.

参见图3和图6,第一锚固钩310、第二锚固钩320和第三锚固钩330的顶端与外层架体上的水平交界面F齐平,第一锚固钩310的最低底端低于第二锚固钩320和第三锚固钩330的最低底端。Referring to Figures 3 and 6, the tops of the first anchor hook 310, the second anchor hook 320 and the third anchor hook 330 are flush with the horizontal interface F on the outer frame body, and the lowest bottom end of the first anchor hook 310 is lower than at the lowest bottom ends of the second anchor hook 320 and the third anchor hook 330 .

在一些实施例中,外层支架100的侧向投影高度为28-33mm。第一锚固钩310的个数为3个,侧向投影高度为10-17mm;第一锚固钩310的下延部301与瓣膜支架轴心的角度a为25-50°。第二锚固钩320的个数为3个,侧向投影高度为8-14mm,第二锚固钩320的下延部301与瓣膜支架轴心的角度β为25-35°。第三锚固钩330的个数为3个,侧向投影高度为8-14mm,第三锚固钩330的下延部301与瓣膜支架轴心的角度γ为20-35°。相较于第一锚固钩310和第二锚固钩320,第三锚固钩330的纵向距离要长,因为原生前叶较长,这样的设计能更好地钩住前叶。第一锚固钩310和第二锚固钩320的高度与角度也是根据原生瓣环及周边原生组织的尺寸进行设计,因此本申请中的锚固组件300在瓣膜假体被植入原生瓣环的位置处时能够使瓣膜支架实现牢固的锚定。In some embodiments, the lateral projected height of the outer stent 100 is 28-33 mm. The number of the first anchor hooks 310 is three, and the lateral projection height is 10-17 mm; the angle a between the downward extension 301 of the first anchor hook 310 and the axis of the valve stent is 25-50°. The number of the second anchor hooks 320 is three, the lateral projection height is 8-14 mm, and the angle β between the downward extension 301 of the second anchor hook 320 and the axis of the valve stent is 25-35°. The number of the third anchor hooks 330 is three, the lateral projection height is 8-14 mm, and the angle γ between the downward extension 301 of the third anchor hook 330 and the axis of the valve stent is 20-35°. Compared with the first anchor hook 310 and the second anchor hook 320, the longitudinal distance of the third anchor hook 330 is longer because the native front leaf is longer, and this design can hook the front leaf better. The height and angle of the first anchor hook 310 and the second anchor hook 320 are also designed according to the size of the native valve annulus and surrounding native tissue. Therefore, the anchoring component 300 in this application is at the position where the valve prosthesis is implanted into the native valve annulus. The valve stent can be firmly anchored.

实施例2Example 2

本实施例提供一种瓣膜支架,其包括外层支架100、内层支架200和锚固组件300。本实施例中外层支架100和内层支架200的结构与实施例1中外层支架100和内层支架200的结构和连接方式可采用相同的方案,其不同之处在于锚固组件300的位置不同。This embodiment provides a valve stent, which includes an outer stent 100 , an inner stent 200 and an anchoring component 300 . The structure and connection method of the outer stent 100 and the inner stent 200 in this embodiment can be the same as the structure and connection method of the outer stent 100 and the inner stent 200 in Embodiment 1, except that the position of the anchoring component 300 is different.

参见图10,锚固组件300设置在外层支架100的底部,且每个锚固钩与外层支架100一体成型。第一锚固钩310、第二锚固钩320和第三锚固钩330的顶端与外层架体上的水平交界面F齐平,第一锚固钩310的最低底端低于第二锚固钩320和第三锚固钩330的最低底端。Referring to FIG. 10 , the anchor assembly 300 is disposed at the bottom of the outer bracket 100 , and each anchor hook is integrally formed with the outer bracket 100 . The top ends of the first anchor hook 310, the second anchor hook 320 and the third anchor hook 330 are flush with the horizontal interface F on the outer frame body, and the lowest bottom end of the first anchor hook 310 is lower than the second anchor hook 320 and the third anchor hook 330. The lowest bottom end of the third anchor hook 330 .

在一些实施例中,外层支架100的侧向投影高度为28-33mm。第一锚固钩310的个数为3个,侧向投影高度为10-17mm;第一锚固钩310的下延部301的中心线与瓣膜支架轴心的角度a为25-50°。第二锚固钩320的个数为3个,侧向投影高度为8-14mm,第二锚固钩320的下延部301与瓣膜支架轴心的角度β为25-35°。第三锚固钩330的个数为2个,侧向投影高度为8-14mm,第三锚固钩330的下延部301与瓣膜支架轴心的角度γ为20-35°。相较于第一锚固钩310和第二锚固钩320,第三锚固钩330的纵向距离要长,这样第三锚固钩330能够更好地钩住前叶。第一锚固钩310和第二锚固钩320的高度与角度也是根据原生瓣环及周边原生组织的尺寸进行设计,因此本实施例中的锚固组件300在瓣膜假体被植入原生瓣环的位置处时能够使瓣膜支架实现牢固的锚定。In some embodiments, the lateral projected height of the outer stent 100 is 28-33 mm. The number of the first anchor hooks 310 is three, and the lateral projection height is 10-17 mm; the angle a between the center line of the downward extension 301 of the first anchor hook 310 and the axis of the valve stent is 25-50°. The number of the second anchor hooks 320 is three, the lateral projection height is 8-14 mm, and the angle β between the downward extension 301 of the second anchor hook 320 and the axis of the valve stent is 25-35°. The number of the third anchor hooks 330 is 2, the lateral projection height is 8-14 mm, and the angle γ between the downward extension 301 of the third anchor hook 330 and the axis of the valve stent is 20-35°. Compared with the first anchor hook 310 and the second anchor hook 320, the longitudinal distance of the third anchor hook 330 is longer, so that the third anchor hook 330 can better hook the front leaf. The height and angle of the first anchor hook 310 and the second anchor hook 320 are also designed according to the size of the native valve annulus and surrounding native tissue. Therefore, the anchoring component 300 in this embodiment is at the position where the valve prosthesis is implanted into the native valve annulus. The valve stent can be firmly anchored at all times.

锚固组件300连接在外层支架100上,有利于减少由于锚固钩受到原生瓣叶带动而影响内层支架200的变形,且每个锚固钩的角度调整更加灵活。The anchor assembly 300 is connected to the outer stent 100, which is beneficial to reducing the deformation of the inner stent 200 caused by the anchor hooks being driven by the native leaflets, and the angle adjustment of each anchor hook is more flexible.

实施例3Example 3

本实施例提供一种瓣膜假体,该瓣膜假体可以用于替换人体的三尖瓣。This embodiment provides a valve prosthesis that can be used to replace the tricuspid valve of the human body.

本实施例与实施例1、2的区别在于,如图11和图12所示,瓣膜假体还包括缝合膜400和瓣叶组件500。所述缝合膜400整体包裹瓣膜支架形成密封结构。瓣叶组件500包括三个瓣叶,瓣叶组件500缝合于包裹在内层支架200侧壁处的缝合膜400上。The difference between this embodiment and Embodiments 1 and 2 is that, as shown in Figures 11 and 12, the valve prosthesis also includes a suture membrane 400 and a valve leaflet assembly 500. The suture membrane 400 integrally wraps the valve stent to form a sealing structure. The leaflet assembly 500 includes three leaflets, and the leaflet assembly 500 is sutured on the suture membrane 400 wrapped at the side wall of the inner stent 200 .

所述缝合膜400为可选PET、PTFE、ePTFE、PU等生物相容性好且容易内皮化的材料、或生物组织材料如猪心包、牛心包。The suture membrane 400 can be made of PET, PTFE, ePTFE, PU and other materials with good biocompatibility and easy endothelialization, or biological tissue materials such as porcine pericardium and bovine pericardium.

瓣叶组件500包括三片人工瓣叶,瓣叶的一端与内层支架200上的缝合膜400稳定连接,瓣叶的另一端为自由端。在工作状态下,由人工瓣叶替代原生瓣叶实现打开和关闭血液通道的功能。The valve leaflet assembly 500 includes three artificial valve leaflets. One end of the valve leaflet is stably connected to the suture membrane 400 on the inner stent 200, and the other end of the valve leaflet is a free end. In the working state, the artificial valve leaflets replace the native valve leaflets to realize the function of opening and closing the blood channel.

当瓣叶组件500呈打开状态时,三片瓣叶的自由端靠近内层支架200侧壁,使血液可以在从内层支架200内侧通过;当瓣叶组件500呈闭合状态时,所有瓣叶的自由端远离内层支架200侧壁的缝合膜400,相邻的两个瓣叶上的自由端至少部分交叠。When the leaflet assembly 500 is in the open state, the free ends of the three leaflets are close to the side walls of the inner stent 200, allowing blood to pass through the inner side of the inner stent 200; when the leaflet assembly 500 is in the closed state, all leaflets The free end is away from the suture membrane 400 on the side wall of the inner stent 200, and the free ends on the two adjacent leaflets at least partially overlap.

在通过输送系统向人体内植入该瓣膜假体时,该假体收束于输送系统内,在人体内的植入位置处,参见图13。该瓣膜假体释放后自动膨开或通过球囊加压扩张,限位在三尖瓣瓣环600上,使外层支架100的长轴尖端位于前叶和隔叶中间的位置。第一锚固钩310需钩住原生腱索,第二锚固钩320与外层支架100表面位于原生瓣叶的两侧并通过两者之间的间距能够夹持在后叶上,第三锚固钩330与外层支架100表面位于原生瓣叶的两侧并通过两者之间的间距能够夹持在前叶上。When the valve prosthesis is implanted into the human body through the delivery system, the prosthesis is bundled in the delivery system at the implantation position in the human body, see Figure 13. The valve prosthesis automatically expands after release or is expanded by balloon pressure, and is limited on the tricuspid valve annulus 600 so that the long axis tip of the outer stent 100 is located between the anterior leaflet and the septal leaflet. The first anchoring hook 310 needs to hook the native tendineae, the second anchoring hook 320 and the surface of the outer stent 100 are located on both sides of the native valve leaflet and can be clamped on the posterior leaflet through the distance between them, and the third anchoring hook The surfaces of 330 and the outer stent 100 are located on both sides of the native valve leaflet and can be clamped on the anterior leaflet through the distance between them.

外层支架100的最大支撑轮廓稍大于人体瓣环(可以为瓣环轮廓的1.1-1.2倍),当植入于人体的瓣环后,外层支架100卡在人体的三尖瓣瓣环600处,从而使瓣膜支架与人体瓣环适度过盈配合以实现瓣膜假体在瓣环处的限位,并避免瓣周漏。The maximum support contour of the outer stent 100 is slightly larger than the human valve annulus (can be 1.1-1.2 times the valve annulus contour). When implanted in the human valve annulus, the outer stent 100 is stuck in the human body's tricuspid valve annulus 600 position, so that the valve stent and the human valve annulus have a moderate interference fit to limit the position of the valve prosthesis at the valve annulus and avoid paravalvular leakage.

这种设计在保持较好径向支撑效果的前提下,对患者原生组织伤害较小,同时还能维持瓣膜假体的整体稳定性。This design does less harm to the patient's native tissue while maintaining good radial support effect, while maintaining the overall stability of the valve prosthesis.

显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属领域技术人员能很好地利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。Obviously, many modifications and variations are possible in light of the contents of this specification. These embodiments are selected and described in detail in this specification to better explain the principles and practical applications of the present invention, so that those skilled in the art can make good use of the present invention. The invention is limited only by the claims and their full scope and equivalents.

Claims (19)

1.一种瓣膜支架,其特征在于,包括:1. A valve stent, characterized in that it includes: 外层支架,其垂向投影的外轮廓呈椭圆形或类椭圆形;The outer stent has an elliptical or elliptical-like outer contour in vertical projection; 内层支架,置于所述外层支架内并与所述外层支架之间保持预定间隙;所述内层支架用于构造出筒状流道;所述内层支架的顶部与所述外层支架的顶部可拆卸连接;The inner bracket is placed in the outer bracket and maintains a predetermined gap with the outer bracket; the inner bracket is used to construct a cylindrical flow channel; the top of the inner bracket is in contact with the outer bracket. The top of the layer bracket is removable; 锚固组件,包括多个锚固钩,多个锚固钩安装于外层支架的底部或所述内层支架的底部,所述多个锚固钩具有不同弯折角度和长度,每个锚固钩的尾端与外层支架的外轮廓面抵接。An anchor assembly includes a plurality of anchor hooks. The plurality of anchor hooks are installed at the bottom of the outer bracket or the bottom of the inner bracket. The plurality of anchor hooks have different bending angles and lengths. The tail end of each anchor hook Contact with the outer surface of the outer bracket. 2.根据权利要求1所述的瓣膜支架,其特征在于,所述外层支架垂向投影的外轮廓被划分为多条曲线段,垂向投影落入同一曲线段的锚固钩的弯折角度和长度相同。2. The valve stent according to claim 1, characterized in that the vertically projected outer contour of the outer stent is divided into a plurality of curved segments, and the vertical projection falls into the bending angle of the anchoring hook of the same curved segment. Same as length. 3.根据权利要求2所述的瓣膜支架,其特征在于,所述内层支架的垂向投影为圆形或圆环形;锚固组件中锚固钩的垂向投影延伸线相交于所述圆形或圆环形的圆心并均分所述圆形或圆环形。3. The valve stent according to claim 2, wherein the vertical projection of the inner stent is circular or annular; the vertical projection extension line of the anchor hook in the anchor assembly intersects with the circular shape. or the center of a donut shape and equally divides said circle or donut shape. 4.根据权利要求1所述的瓣膜支架,其特征在于,所述内层支架的垂向投影为椭圆形或类椭圆形;所述内层支架的垂向投影与所述外层支架的垂向投影同中心且平行。4. The valve stent according to claim 1, wherein the vertical projection of the inner stent is oval or elliptical-like; the vertical projection of the inner stent is the same as the vertical projection of the outer stent. Projections are concentric and parallel. 5.根据权利要求1所述的瓣膜支架,其特征在于,所述外层支架包括沿瓣膜支架轴向依次布置的渐缩部、支撑部和支架部;所述渐缩部自所述支撑部的顶部向所述瓣膜支架的轴心方向渐缩收拢;所述支撑部和所述支架部的交界处为水平交界面;5. The valve stent according to claim 1, wherein the outer stent includes a tapered portion, a supporting portion and a stent portion arranged sequentially along the axial direction of the valve stent; the tapered portion extends from the supporting portion. The top of the valve stent gradually shrinks toward the axial direction of the valve stent; the interface between the support part and the stent part is a horizontal interface; 所述锚固组件中锚固钩的尾端与所述水平交界面对齐。The tail end of the anchor hook in the anchor assembly is aligned with the horizontal interface. 6.根据权利要求5所述的瓣膜支架,其特征在于,所述椭圆形或类椭圆形轮廓划分为第一曲线段、第二曲线段和第三曲线段;6. The valve stent according to claim 5, wherein the oval or elliptical-like outline is divided into a first curve segment, a second curve segment and a third curve segment; 所述第一曲线段包含椭圆形或类椭圆形轮廓的长轴尖端,所述外层支架中垂向投影为第一曲线段的架体被配置在隔叶区;垂向投影为第二曲线段的架体被配置在后叶区;垂向投影为第三曲线段的架体被配置在前叶区。The first curve segment includes the tip of the major axis of an elliptical or elliptical profile, and the frame body of the outer stent whose vertical projection is the first curve segment is configured in the partition area; the vertical projection is the second curve The frame body of the segment is arranged in the posterior leaf area; the frame body of the vertically projected third curve segment is arranged in the front leaf area. 7.根据权利要求6所述的瓣膜支架,其特征在于,所述锚固钩的个数为6-9个,所述第一曲线段、第二曲线段和第三曲线段对应的锚固钩的个数均为2-3个。7. The valve stent according to claim 6, wherein the number of anchor hooks is 6-9, and the anchor hooks corresponding to the first curve segment, the second curve segment and the third curve segment are The number is 2-3. 8.根据权利要求6所述的瓣膜支架,其特征在于,垂向投影位于第一曲线段内的锚固钩为第一锚固钩;垂向投影位于第二曲线段内的锚固钩为第二锚固钩;垂向投影位于第三曲线段内的锚固钩为第三锚固钩;8. The valve stent according to claim 6, characterized in that the anchor hooks located in the first curve segment in vertical projection are the first anchor hooks; the anchor hooks located in the second curve segment in vertical projection are the second anchors. hook; the anchor hook whose vertical projection is located within the third curve segment is the third anchor hook; 所述瓣膜支架的侧向投影高度为28-33mm;第一锚固钩的侧向投影高度为10-17mm;第二锚固钩的侧向投影高度为8-14mm;第三锚固钩的侧向投影高度为8-14mm。The lateral projection height of the valve stent is 28-33mm; the lateral projection height of the first anchor hook is 10-17mm; the lateral projection height of the second anchor hook is 8-14mm; the lateral projection height of the third anchor hook Height is 8-14mm. 9.根据权利要求8所述的瓣膜支架,其特征在于,所述锚固钩包括下延部、弯折部和上延部;9. The valve stent according to claim 8, wherein the anchor hook includes a downward extension, a bending part and an upward extension; 第一锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为20-35°;第二锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为25-35°;第三锚固钩的下延部的中心线与所述瓣膜支架轴心的角度为25-50°。The angle between the center line of the downward extension of the first anchor hook and the axis of the valve stent is 20-35°; the angle between the center line of the downward extension of the second anchor hook and the axis of the valve stent is 25-35°. °; The angle between the center line of the lower extension of the third anchor hook and the axis of the valve stent is 25-50°. 10.根据权利要求6所述的瓣膜支架,其特征在于,所述支架部包括周向阵列的多个V形结构,所述支撑部包括周向阵列的多个W形结构,所述渐缩部包括周向阵列的多个Y形结构;10. The valve stent according to claim 6, wherein the stent portion includes a plurality of V-shaped structures in a circumferential array, the support portion includes a plurality of W-shaped structures in a circumferential array, and the tapered The portion includes a plurality of Y-shaped structures in a circumferential array; V形结构、W形结构和Y形结构的数量一一对应,每个V形结构的两个顶端与其对应的W形结构的两个底端固定连接;Y形结构的两个底端与W形结构的两个顶端连接,Y形结构向所述瓣膜支架的轴心方向渐缩收拢,且在其顶端设有与所述内层支架连接的凸点。The numbers of V-shaped structures, W-shaped structures and Y-shaped structures correspond one to one. The two top ends of each V-shaped structure are fixedly connected to the two bottom ends of the corresponding W-shaped structure; the two bottom ends of the Y-shaped structure are connected to the W-shaped structure. The two top ends of the Y-shaped structure are connected, the Y-shaped structure gradually shrinks toward the axial direction of the valve stent, and a protruding point connected to the inner layer stent is provided on its top end. 11.根据权利要求10所述的瓣膜支架,其特征在于,V形结构的两个顶端和W形结构的两个底端一体成型。11. The valve stent according to claim 10, wherein the two top ends of the V-shaped structure and the two bottom ends of the W-shaped structure are integrally formed. 12.根据权利要求10所述的瓣膜支架,其特征在于,所述内层支架为两端开口的筒形结构,所述筒形结构的顶端设有用于与所述凸点连接的锚点。12. The valve stent according to claim 10, wherein the inner stent is a cylindrical structure with both ends open, and the top of the cylindrical structure is provided with an anchor point for connecting to the bump. 13.根据权利要求12所述的瓣膜支架,其特征在于,所述凸点与锚点的连接方式包括焊接、铆接、压接、缝合连接中的一种或多种组合。13. The valve stent according to claim 12, wherein the connection method between the protruding point and the anchor point includes one or more combinations of welding, riveting, crimping, and suture connection. 14.根据权利要求1所述的瓣膜支架,其特征在于,所述外层支架上设置有针刺,所述针刺的一端连接于外层支架外表面,另一端倾斜朝向瓣膜支架的外侧。14. The valve stent according to claim 1, wherein the outer stent is provided with acupuncture, one end of the acupuncture is connected to the outer surface of the outer stent, and the other end is inclined toward the outside of the valve stent. 15.根据权利要求1所述的瓣膜支架,其特征在于,所述锚固钩弯折朝向外层支架外表面的表面上设置有针刺,所述针刺朝向所述外层支架。15. The valve stent according to claim 1, wherein the anchoring hook is provided with acupuncture on a surface bent toward the outer surface of the outer stent, and the acupuncture is directed toward the outer stent. 16.根据权利要求1所述的瓣膜支架,其特征在于,所述外层支架的顶端高于或等于内层支架的顶端,所述外层支架的最低端高于或等于所述内层支架的最低端。16. The valve stent according to claim 1, wherein the top end of the outer stent is higher than or equal to the top end of the inner stent, and the lowest end of the outer stent is higher than or equal to the inner stent. the lowest end. 17.根据权利要求1至16中任一项所述的瓣膜支架,其特征在于,所述外层支架的最大支撑轮廓为原生瓣环轮廓的1.1-1.2倍。17. The valve stent according to any one of claims 1 to 16, wherein the maximum support profile of the outer stent is 1.1-1.2 times the native valve annulus profile. 18. 根据权利要求17所述的瓣膜支架,其特征在于,所述内层支架的支撑轮廓周长与所述外层支架的支撑轮廓周长之比为1 : 2 – 3 : 5。18. The valve stent according to claim 17, wherein the ratio of the support profile circumference of the inner stent to the support profile circumference of the outer stent is 1:2-3:5. 19.一种瓣膜假体,其特征在于,包括权利要求1-18任一项所述的瓣膜支架,以及缝合膜和瓣叶,所述缝合膜围设于所述外层支架和内层支架以形成密封结构;所述瓣叶固定连接于所述内层支架侧壁处的缝合膜上。19. A valve prosthesis, characterized by comprising the valve stent according to any one of claims 1 to 18, and a suture membrane and a valve leaflet, the suture membrane surrounding the outer stent and the inner stent. To form a sealing structure; the leaflets are fixedly connected to the suture membrane at the side wall of the inner stent.
CN202311360161.7A 2023-10-20 2023-10-20 Valve stent and valve prosthesis Active CN117100459B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN202311360161.7A CN117100459B (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis
CN202411010087.0A CN118924494A (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202311360161.7A CN117100459B (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202411010087.0A Division CN118924494A (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis

Publications (2)

Publication Number Publication Date
CN117100459A true CN117100459A (en) 2023-11-24
CN117100459B CN117100459B (en) 2024-08-20

Family

ID=88795030

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202311360161.7A Active CN117100459B (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis
CN202411010087.0A Pending CN118924494A (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202411010087.0A Pending CN118924494A (en) 2023-10-20 2023-10-20 Valve stent and valve prosthesis

Country Status (1)

Country Link
CN (2) CN117100459B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117959039A (en) * 2024-03-28 2024-05-03 上海欣吉特生物科技有限公司 An artificial tricuspid valve prosthesis
CN118000970A (en) * 2024-03-12 2024-05-10 广东省人民医院 Valve outer support, inner support and valve are intervened to tricuspid valve
CN120241326A (en) * 2025-03-31 2025-07-04 北京新尖科技有限公司 Anchoring hook, valve stent and valve prosthesis

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049494A1 (en) * 2000-10-10 2002-04-25 Biotronik Mess-Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Stent
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
CN107920862A (en) * 2014-10-23 2018-04-17 凯森因特万逊奈尔有限公司 System and method for cardiac valves therapy
US20190091022A1 (en) * 2017-03-17 2019-03-28 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
CN109843219A (en) * 2016-08-26 2019-06-04 爱德华兹生命科学公司 multi-part replacement heart valve prosthesis
CN111110398A (en) * 2018-10-30 2020-05-08 上海微创心通医疗科技有限公司 Split type heart valve support and prosthesis thereof
CN112022246A (en) * 2020-11-06 2020-12-04 上海介入医疗器械有限公司 Left auricle occluder and use method thereof
CN112118811A (en) * 2018-06-13 2020-12-22 恩多隆医疗有限公司 Graft fixation systems, applicators, and methods
CN114028030A (en) * 2021-11-09 2022-02-11 上海臻亿医疗科技有限公司 Artificial heart valve
CN114191146A (en) * 2021-12-31 2022-03-18 上海蓝帆博奥医疗科技有限公司 Valve support and artificial valve device comprising same
CN115153964A (en) * 2022-07-14 2022-10-11 北京心脉医疗科技有限公司 A heart valve replacement prosthesis
CN115969434A (en) * 2022-02-28 2023-04-18 上海介入医疗器械有限公司 Left auricle plugging device and left auricle plugging assembly

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020049494A1 (en) * 2000-10-10 2002-04-25 Biotronik Mess-Und Therapiegeraete Gmbh & Co. Ingenieurbuero Berlin Stent
US20040034411A1 (en) * 2002-08-16 2004-02-19 Quijano Rodolfo C. Percutaneously delivered heart valve and delivery means thereof
CN107920862A (en) * 2014-10-23 2018-04-17 凯森因特万逊奈尔有限公司 System and method for cardiac valves therapy
CN109843219A (en) * 2016-08-26 2019-06-04 爱德华兹生命科学公司 multi-part replacement heart valve prosthesis
US20190091022A1 (en) * 2017-03-17 2019-03-28 Valcare, Inc. Mitral or tricuspid repair systems with multi-directional anchors
CN112118811A (en) * 2018-06-13 2020-12-22 恩多隆医疗有限公司 Graft fixation systems, applicators, and methods
CN111110398A (en) * 2018-10-30 2020-05-08 上海微创心通医疗科技有限公司 Split type heart valve support and prosthesis thereof
CN112022246A (en) * 2020-11-06 2020-12-04 上海介入医疗器械有限公司 Left auricle occluder and use method thereof
CN114028030A (en) * 2021-11-09 2022-02-11 上海臻亿医疗科技有限公司 Artificial heart valve
CN114191146A (en) * 2021-12-31 2022-03-18 上海蓝帆博奥医疗科技有限公司 Valve support and artificial valve device comprising same
CN115969434A (en) * 2022-02-28 2023-04-18 上海介入医疗器械有限公司 Left auricle plugging device and left auricle plugging assembly
CN115153964A (en) * 2022-07-14 2022-10-11 北京心脉医疗科技有限公司 A heart valve replacement prosthesis

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118000970A (en) * 2024-03-12 2024-05-10 广东省人民医院 Valve outer support, inner support and valve are intervened to tricuspid valve
CN118000970B (en) * 2024-03-12 2024-12-20 广东省人民医院 Valve outer support, inner support and valve are intervened to tricuspid valve
WO2025189897A1 (en) * 2024-03-12 2025-09-18 广东省人民医院 Tricuspid valve interventional valve outer stent and inner stent, and tricuspid valve interventional valve
CN117959039A (en) * 2024-03-28 2024-05-03 上海欣吉特生物科技有限公司 An artificial tricuspid valve prosthesis
CN120241326A (en) * 2025-03-31 2025-07-04 北京新尖科技有限公司 Anchoring hook, valve stent and valve prosthesis

Also Published As

Publication number Publication date
CN117100459B (en) 2024-08-20
CN118924494A (en) 2024-11-12

Similar Documents

Publication Publication Date Title
CN108578016B (en) Trans-apex implantable mitral valve device
CN106420114B (en) A kind of heart valve prosthesis
CA3040022C (en) Heart valve prosthesis anchored to interventricular septum and conveying and releasing method thereof
JP6473682B2 (en) Implantable device for treating heart valve regurgitation
CN108156805B (en) Mitral valve assembly
CN111772878B (en) Heart valve prosthesis
CN117100459B (en) Valve stent and valve prosthesis
US9089424B2 (en) Aortic annuloplasty ring
CN105658179B (en) For the device and method of mitral regurgitation method
WO2022151622A1 (en) Valve prosthesis and valve prosthesis system
US20200069419A1 (en) Device for treatment of valve regurgitation
EP2695587A1 (en) Medical apparatus for the therapeutic treatment of an insufficient cardiac valve
CN209091745U (en) Split type heart valve bracket and its prosthese
CN209377809U (en) A kind of heart valve prosthesis prosthese and its bracket
JP2013542761A (en) Intra-annular mounting frame for aortic valve repair
WO2022007384A1 (en) Composite-type skirt for prosthetic heart valve and prosthetic heart valve
CN112022439A (en) Artificial heart valve
CN114869544A (en) Valve leaflet capturing device and system and artificial heart valve
CN115212010A (en) an artificial heart valve
CN111772879B (en) An artificial heart valve
WO2025112789A1 (en) Valve stent and artificial valve
CN115105264A (en) Valve stent and valve prosthesis system
CN111904664A (en) Tricuspid valve prosthesis
WO2023185248A1 (en) Cusp-capturing apparatus and system, and artificial heart valve system
CN113558822B (en) An interventional mitral valve replacement system

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant